Alicia Mozzachio InspectorProfile

This FDA InspectorProfile is a report of relevant audit-related information on Alicia Mozzachio, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.

Product Description

This InspectorProfile report is updated through Mar 2018 and lists Alicia Mozzachio's inspections in 26 countries: United States, Hungary, United Arab Emirates, Israel, India, Turkey, South Africa, Brazil, United Kingdom, Latvia, Italy, Germany, Spain, Jordan, Netherlands, Poland, Denmark, Taiwan, China, Singapore, France, Japan, Ireland, Czech Republic, Austria, and Korea (the Republic of).

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Alicia Mozzachio's inspection information so that you can mitigate investigator-related risks.

Example Report

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Alicia Mozzachio.

Product details

• Alicia Mozzachio's metrics:
  • 483 issue rate, total inspections, total 483s
  • Most common citations (based on CFR), CFR description, and citation frequency
  • Total inspections, total 483s
  • Longest / shortest inspection in duration - all time, last year
  • Total warning letters
• Inspection details for each inspection (since 2000) Alicia Mozzachio has conducted including:
  • Company, site inspected, duration of inspection
  • Co-inspectors Viviana Matta, Thuy Nguyen, William Fritsch, Timothy Pohlhaus, Raphael Brykman, year of last co-inspection, number of co-inspections
  • If a 483 issued, and whether or not it resulted in a warning letter.

Note: The EIR and 483 documents are sold separately.